Dashboard
Manage Tickers

GANXGain Therapeutics, Inc.

Nasdaq gaintherapeutics.com


$ 1.22 $ 0.06 (5.17 %)    

Tuesday, 10-Sep-2024 10:38:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.30 $ -1.06 (-0.23 %)
DIA $ 407.45 $ -2.16 (-0.53 %)
SPY $ 546.36 $ -2.03 (-0.37 %)
TLT $ 100.42 $ 0.51 (0.51 %)
GLD $ 231.90 $ -0.51 (-0.22 %)
$ 1.16
$ 1.22
$ 1.22 x 100
-- x --
$ 1.20 - $ 1.22
$ 0.89 - $ 5.33
294,856
na
29.62M
$ 0.80
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-26-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-25-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-gain-therapeutics-maintains-8-price-target
HC Wainwright & Co. Reiterates Buy on Gain...
09/03/2024 11:32:42

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Gain Therapeutics (NASDAQ:GANX) with a Buy and maintains $8 pr...

small-cap-gain-therapeutics-stock-falls-on-phase-1-data-from-its-lead-asset-for-parkinsons-disease
Small-Cap Gain Therapeutics Stock Falls On...
08/29/2024 16:05:55

Gain Therapeutics reported positive Phase 1 results for GT-02287, showing safety and tolerability across all age groups. The co...

gain-therapeutics-announces-topline-results-from-phase-1-clinical-trial-of-gt-02287-says-review-confirmed-single-and-multiple-doses-were-safe-and-generally-well-tolerated-up-to-and-including-highest-planed-dose-levels-across-age-groups
Gain Therapeutics Announces Topline Result...
08/29/2024 11:32:43

oppenheimer-assumes-gain-therapeutics-at-outperform-announces-price-target-of-8
Oppenheimer Assumes Gain Therapeutics at O...
08/14/2024 12:04:14

Oppenheimer analyst Jay Olson assumes Gain Therapeutics (NASDAQ:GANX) with a Outperform rating and announces Price Target of...

chardan-capital-maintains-buy-on-gain-therapeutics-maintains-6-price-target
Chardan Capital Maintains Buy on Gain Ther...
08/09/2024 21:16:46

Chardan Capital analyst Keay Nakae maintains Gain Therapeutics (NASDAQ:GANX) with a Buy and maintains $6 price target.

gain-therapeutics-q2-2024-gaap-eps-042-misses-020-estimate
Gain Therapeutics Q2 2024 GAAP EPS $(0.42)...
08/08/2024 11:49:31

Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $...

hc-wainwright--co-reiterates-buy-on-gain-therapeutics-maintains-8-price-target
HC Wainwright & Co. Reiterates Buy on Gain...
07/11/2024 10:24:54

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Gain Therapeutics (NASDAQ:GANX) with a Buy and maintains $8 pr...

gain-therapeutics-advances-parkinsons-therapy-with-successful-phase-1-results-for-gt-02287
Gain Therapeutics Advances Parkinson's The...
07/09/2024 11:04:42

Gain Therapeutics, Inc. (NASDAQ:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leadin...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
07/04/2024 12:06:00

hc-wainwright--co-maintains-buy-on-gain-therapeutics-lowers-price-target-to-8
HC Wainwright & Co. Maintains Buy on Gain ...
07/02/2024 10:15:25

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Gain Therapeutics (NASDAQ:GANX) with a Buy and lowers the price...

gain-therapeutics-appoints-gene-mack-as-interim-ceo
Gain Therapeutics Appoints Gene Mack As In...
06/27/2024 20:09:16

gain-therapeutics-presents-gt-02287-data-at-fens-forum-2024
Gain Therapeutics Presents GT-02287 Data A...
06/27/2024 12:36:53

sp-500-edges-lower-rh-shares-plunge-after-q1-results
S&P 500 Edges Lower; RH Shares Plunge Afte...
06/14/2024 19:36:13

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session
Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
06/14/2024 16:31:56

gold-gains-1-us-consumer-sentiment-falls-in-june
Gold Gains 1%; US Consumer Sentiment Falls...
06/14/2024 16:03:10

dow-tumbles-over-200-points-adobe-earnings-top-views
Dow Tumbles Over 200 Points; Adobe Earning...
06/14/2024 14:01:24

why-adobe-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Adobe Shares Are Trading Higher By Aro...
06/14/2024 12:19:25

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
06/14/2024 12:06:22

reported-earlier-gain-therapeutics-prices-11m-public-offering-of-7116547-common-shares-at-135share-and-pre-funded
Reported Earlier, Gain Therapeutics Prices...
06/14/2024 06:25:08

Gain Therapeutics announced the pricing of an underwritten public offering of (i) 7,116,547 shares of its common stock at a pub...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION